{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:21:55Z","timestamp":1793125315875,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection Prevention in Practice"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.infpip.2024.100426","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T12:17:05Z","timestamp":1732882625000},"page":"100426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence of difficult-to-treat resistance in ESKAPE pathogens in a third level hospital in Mexico"],"prefix":"10.1016","volume":"7","author":[{"given":"Adri\u00e1n","family":"Camacho-Ortiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Flores-Trevi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4602-3817","authenticated-orcid":false,"given":"Paola","family":"Bocanegra-Ibarias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.infpip.2024.100426_bib1","series-title":"Antibiotic resistance threats in the United States Atlanta, GA: U.S.: department of health and human services","year":"2019"},{"key":"10.1016\/j.infpip.2024.100426_bib2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1159\/000346352","article-title":"One-year surveillance of ESKAPE pathogens in an intensive care unit of Monterrey, Mexico","volume":"58","author":"Llaca-Diaz","year":"2012","journal-title":"Chemotherapy"},{"key":"10.1016\/j.infpip.2024.100426_bib3","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1089\/mdr.2019.0354","article-title":"The Evolution of Antimicrobial Resistance in Mexico During the Last Decade: Results from the INVIFAR Group","volume":"26","author":"Garza-Gonz\u00e1lez","year":"2020","journal-title":"Microb Drug Resist"},{"issue":"3","key":"10.1016\/j.infpip.2024.100426_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial Resistance in ESKAPE Pathogens","volume":"33","author":"Oliveira","year":"2020","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.infpip.2024.100426_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2020.1799654","article-title":"Antimicrobial resistance in enteric bacteria: current state and next-generation solutions","volume":"12","author":"Wallace","year":"2020","journal-title":"Gut Microb"},{"issue":"10","key":"10.1016\/j.infpip.2024.100426_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10101310","article-title":"Bacterial Antibiotic Resistance: The Most Critical Pathogens","volume":"10","author":"Mancuso","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.infpip.2024.100426_bib7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for\u00a0interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.infpip.2024.100426_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.infpip.2024.100426_bib9","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/cid\/ciy378","article-title":"Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents","volume":"67","author":"Kadri","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.infpip.2024.100426_bib10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/MCC.0000000000001074","article-title":"Severe infections caused by difficult-to-treat Gram-negative bacteria","volume":"29","author":"Dettori","year":"2023","journal-title":"Curr Opin Crit Care"},{"issue":"4","key":"10.1016\/j.infpip.2024.100426_bib11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1055\/s-0039-1696662","article-title":"Difficult-to-Treat Antibiotic-Resistant Gram-Negative Pathogens in the Intensive Care Unit: Epidemiology, Outcomes, and Treatment","volume":"40","author":"Strich","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.infpip.2024.100426_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11081009","article-title":"Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients","volume":"11","author":"Giamarellou","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.infpip.2024.100426_bib13","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.2147\/IDR.S365139","article-title":"Trends in DTR, CR, ECR, and FQR in Four Common Gram-Negative Bacteria: A Retrospective Study from 2013 to 2021","volume":"15","author":"Zhang","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.infpip.2024.100426_bib14","article-title":"Difficult-to-treat resistant gram-negative blood stream infections - the beginning of a superbug era - a prospective observational study","volume":"44","author":"Naveenraj","year":"2023","journal-title":"Indian J Med Microbiol"},{"issue":"9","key":"10.1016\/j.infpip.2024.100426_bib15","doi-asserted-by":"crossref","first-page":"e487","DOI":"10.1093\/cid\/ciaa084","article-title":"Impact of Difficult-to-Treat Resistance in Gram-negative Bacteremia on Mortality: Retrospective Analysis of Nationwide Surveillance Data","volume":"71","author":"Huh","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.infpip.2024.100426_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics9090624","article-title":"Prevalence and Antibiotic Resistance of ESKAPE Pathogens Isolated in the Emergency Department of a Tertiary Care Teaching Hospital in Hungary: A 5-Year Retrospective Survey","volume":"9","author":"Benk\u0151","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.infpip.2024.100426_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2021.115512","article-title":"Trends of major antimicrobial resistance phenotypes in enterobacterales and gram-negative non-fermenters from ATLAS and EARS-net surveillance systems: Italian vs. European and global data, 2008-2018","volume":"101","author":"Rossolini","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.infpip.2024.100426_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jhin.2023.05.021","article-title":"Antibiotic resistance in bloodstream isolates from high-complexity paediatric units in Madrid, Spain: 2013-2021","volume":"139","author":"Aguilera-Alonso","year":"2023","journal-title":"J\u00a0Hosp Infect"},{"issue":"12","key":"10.1016\/j.infpip.2024.100426_bib19","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1093\/cid\/ciaa384","article-title":"Gram-negative Bacteria With Difficult-to-Treat Resistance: A Moving Target","volume":"72","author":"Al-Hasan","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.infpip.2024.100426_bib20","series-title":"Performance standards for antimicrobial susceptibility testing. CLSI supplement M100","year":"2018"},{"key":"10.1016\/j.infpip.2024.100426_bib21","series-title":"Performance standards for antimicrobial susceptibility testing. CLSI supplement M100","year":"2019"},{"key":"10.1016\/j.infpip.2024.100426_bib22","series-title":"Performance standards for antimicrobial susceptibility testing. CLSI supplement M100","year":"2020"},{"key":"10.1016\/j.infpip.2024.100426_bib23","series-title":"Performance standards for antimicrobial susceptibility testing. CLSI supplement M100","year":"2021"},{"key":"10.1016\/j.infpip.2024.100426_bib24","series-title":"Performance standards for antimicrobial susceptibility testing. CLSI supplement M100","year":"2022"},{"key":"10.1016\/j.infpip.2024.100426_bib25","series-title":"Performance standards for antimicrobial susceptibility testing. CLSI supplement M100","year":"2023"},{"key":"10.1016\/j.infpip.2024.100426_bib26","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/jac\/dkp244","article-title":"BSAC standardized disc susceptibility testing method (version 8)","volume":"64","author":"Andrews","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.infpip.2024.100426_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55430-1","article-title":"Screening of biomarkers of drug resistance or virulence in ESCAPE pathogens by MALDI-TOF mass spectrometry","volume":"9","author":"Flores-Trevi\u00f1o","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.infpip.2024.100426_bib28","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jiph.2016.10.009","article-title":"Prevalence, antibiotic susceptibility and characterization of antibiotic resistant genes among carbapenem-resistant Gram-negative bacilli and yeast in intestinal flora of cancer patients in North Lebanon","volume":"10","author":"Christophy","year":"2017","journal-title":"J\u00a0Infect Public Health"},{"key":"10.1016\/j.infpip.2024.100426_bib29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijantimicag.2006.01.004","article-title":"Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp","volume":"27","author":"Woodford","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.infpip.2024.100426_bib30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/mdr.2022.0226","article-title":"Carbapenemase-Encoding Genes and Colistin Resistance in Gram-Negative Bacteria During the COVID-19 Pandemic in Mexico: Results from the Invifar Network","volume":"29","author":"Garza-Ramos","year":"2023","journal-title":"Microb Drug Resist"},{"issue":"3","key":"10.1016\/j.infpip.2024.100426_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248614","article-title":"Drug resistance phenotypes and genotypes in Mexico in representative gram-negative species: Results from the infivar network","volume":"16","author":"Garza-Gonz\u00e1lez","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.infpip.2024.100426_bib32","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2147\/IDR.S289499","article-title":"Comparative Evaluation of Seven Tigecycline Susceptibility Testing Methods for Carbapenem-Resistant Enterobacteriaceae","volume":"14","author":"Li","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.infpip.2024.100426_bib33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.diagmicrobio.2018.03.011","article-title":"Comparison of tigecycline susceptibility testing methods for multidrug-resistant Acinetobacter baumannii","volume":"91","author":"Idelevich","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.infpip.2024.100426_bib34","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1128\/JCM.02037-12","article-title":"Comparative evaluation of tigecycline susceptibility testing methods for expanded-spectrum cephalosporin- and carbapenem-resistant gram-negative pathogens","volume":"50","author":"Zarkotou","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"9","key":"10.1016\/j.infpip.2024.100426_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12091144","article-title":"Active Surveillance of Antimicrobial Resistance and Carbapenemase-Encoding Genes According to Sites of Care and Age Groups in Mexico: Results from the INVIFAR Network","volume":"12","author":"Rojas-Larios","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.infpip.2024.100426_bib36","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/cid\/ciaa381","volume":"72","author":"Karlowsky","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.infpip.2024.100426_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/14656566.2020.1817386","article-title":"Therapeutic options for difficult-to-treat Acinetobacter baumannii infections: a 2020 perspective","volume":"22","author":"Bassetti","year":"2021","journal-title":"Expet Opin Pharmacother"},{"issue":"Suppl 2","key":"10.1016\/j.infpip.2024.100426_bib38","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1093\/ofid\/ofz360.747","article-title":"In\u00a0vitro Activity of Cefiderocol (CFDC), a Novel Siderophore Cephalosporin, Against Difficult-to-Treat-Resistant (DTR) Gram-Negative Bacterial Pathogens From the Multi-National Sentinel Surveillance Study, SIDERO-WT (2014\u20132017)","volume":"6","author":"Longshaw","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.infpip.2024.100426_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics12060991","article-title":"Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature Review","volume":"12","author":"Wicky","year":"2023","journal-title":"Antibiotics"}],"container-title":["Infection Prevention in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590088924000908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590088924000908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:24:20Z","timestamp":1739924660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590088924000908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2590088924000908"],"URL":"https:\/\/doi.org\/10.1016\/j.infpip.2024.100426","relation":{},"ISSN":["2590-0889"],"issn-type":[{"value":"2590-0889","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of difficult-to-treat resistance in ESKAPE pathogens in a third level hospital in Mexico","name":"articletitle","label":"Article Title"},{"value":"Infection Prevention in Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.infpip.2024.100426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society.","name":"copyright","label":"Copyright"}],"article-number":"100426"}}